Letters Profits from pregnancy

Products in “Bounty bags” potentially harm newborn skin

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f3895 (Published 18 June 2013) Cite this as: BMJ 2013;346:f3895
  1. Matthew Ridd, GP and National Institute for Health Research clinical trials fellow1,
  2. Richard Guy, professor of pharmaceutical sciences2,
  3. Nicola Ball, community dermatology nurse specialist1,
  4. Amanda Roberts, parent carer and NSGCCE twitterer3,
  5. Hywel Williams, professor of dermato-epidemiology4
  1. 1University of Bristol, Bristol BS8 2PS, UK
  2. 2University of Bath, Bath, UK
  3. 3Nottingham Support Group for Carers of Children with Eczema (NSGCCE), Nottingham, UK
  4. 4Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK
  1. m.ridd{at}bristol.ac.uk

We agree with McCartney that allowing commercial organisations direct access to new mothers through “Bounty bags” is unacceptable.1 MR recently witnessed the giving out of these bags, which starts with “Have you had your free Bounty bag yet?,” quickly followed by “The pack contains the form for you to claim child benefit,” “Can I take some details?,” and the offer …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe